These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 7555207

  • 1. Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
    Nomura S, Nagayama A.
    Chemotherapy; 1995; 41(4):267-75. PubMed ID: 7555207
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
    Nomura S, Nagayama A.
    Chemotherapy; 1995; 41(3):178-86. PubMed ID: 7656663
    [Abstract] [Full Text] [Related]

  • 3. Decrease in surface charge density of Klebsiella pneumoniae treated with cefodizime and enhancement of the phagocytic function of human polymorphonuclear leucocytes stimulated by the drug-treated bacteria.
    Muratsugu M, Miyake Y, Ishida N, Hyodo A, Terayama K.
    Biol Pharm Bull; 1995 Sep; 18(9):1259-63. PubMed ID: 8845818
    [Abstract] [Full Text] [Related]

  • 4. Binding of complement C3 to Klebsiella pneumoniae treated with sub-MIC cefodizime and chemiluminescence response of human polymorphonuclear leukocytes.
    Nomura S, Kuroiwa A, Murata K, Nagayama A.
    Chemotherapy; 1997 Sep; 43(2):132-6. PubMed ID: 9084922
    [Abstract] [Full Text] [Related]

  • 5. Effects of sub-minimal inhibitory concentrations of antimicrobial agents on the cell surface of Klebsiella pneumoniae and phagocytic killing activity.
    Nomura S, Murata K, Nagayama A.
    J Chemother; 1995 Oct; 7(5):406-13. PubMed ID: 8596121
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative activity of cefodizime and ceftriaxone against respiratory pathogens in an in vitro pharmacodynamic model simulating concentration-time curves.
    Blandino G, Milazzo I, Musumeci R, Nicolosi VM, Speciale A, Nicoletti G.
    J Chemother; 2000 Dec; 12(6):503-8. PubMed ID: 11154034
    [Abstract] [Full Text] [Related]

  • 9. Sub-MIC concentrations of cefodizime interfere with various factors affecting bacterial virulence.
    Braga PC, Sasso MD, Sala MT.
    J Antimicrob Chemother; 2000 Jan; 45(1):15-25. PubMed ID: 10629008
    [Abstract] [Full Text] [Related]

  • 10. Bactericidal activity of cefodizime on Enterobacteriaceae in an in-vitro model simulating plasma pharmacokinetics in humans.
    Péchinot A, Neuwirth C, Bryskier A, Duez JM, Kazmierczak A.
    J Antimicrob Chemother; 1997 Feb; 39(2):157-62. PubMed ID: 9069535
    [Abstract] [Full Text] [Related]

  • 11. [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria].
    Soussy CJ, Otterbein G, Le Van Thoi J, Duval J, Chanal M, Cluzel M, Sirot D.
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):561-6. PubMed ID: 3534743
    [Abstract] [Full Text] [Related]

  • 12. Influence of cefodizime on pulmonary inflammatory response to heat-killed Klebsiella pneumoniae in mice.
    Bergeron Y, Deslauriers AM, Ouellet N, Gauthier MC, Bergeron MG.
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2291-4. PubMed ID: 10471581
    [Abstract] [Full Text] [Related]

  • 13. Comparative in vitro activity of cefodizime and other antibiotics against pathogens recently isolated in Italy.
    Nicoletti G, Blandino G, Cocuzza G, Dainelli B, Maida A, Debbia E, Schito G.
    Chemotherapy; 1996 Sep; 42(2):100-6. PubMed ID: 8697884
    [Abstract] [Full Text] [Related]

  • 14. In vitro antimicrobial activity of cefodizime, a third generation cephalosporin.
    Pruksachatvuthi S, Aswapokee N, Aswapokee P.
    J Med Assoc Thai; 1992 May; 75(5):287-92. PubMed ID: 1460409
    [Abstract] [Full Text] [Related]

  • 15. Comparison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro.
    Labro MT, el Benna J.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():49-57. PubMed ID: 2127416
    [Abstract] [Full Text] [Related]

  • 16. Comparative bacteriostatic and bactericidal activities of cefodizime against Borrelia burgdorferi sensu lato.
    Murgia R, Marchetti F, Cinco M.
    Antimicrob Agents Chemother; 1999 Dec; 43(12):3030-2. PubMed ID: 10582905
    [Abstract] [Full Text] [Related]

  • 17. [Antimicrobial activity of cefodizime against clinical isolates].
    Suzuki Y, Ishihara R, Ishii Y, Nakazawa A, Deguchi K, Matsumoto Y, Nishinari C, Nakane Y, Fukumoto T.
    Jpn J Antibiot; 1996 Oct; 49(10):947-65. PubMed ID: 8986558
    [Abstract] [Full Text] [Related]

  • 18. [Influence of sub-mics of selected antibiotics on hydrophobic and adhering properties of Klebsiella pneumoniae strains isolated from urine samples].
    Sekowska A, Gospodarek E, Wróblewska J.
    Med Dosw Mikrobiol; 2008 Oct; 60(4):297-302. PubMed ID: 19382601
    [Abstract] [Full Text] [Related]

  • 19. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A, Major P.
    Microb Drug Resist; 1996 Oct; 2(3):361-9. PubMed ID: 9158796
    [Abstract] [Full Text] [Related]

  • 20. Changes in serum sensitivity and hydrophobicity in a clinical isolate of Klebsiella pneumoniae treated with subinhibitory concentrations of aminoglycosides.
    Hostacká A.
    Zentralbl Bakteriol; 1998 Dec; 288(4):519-26. PubMed ID: 9987190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.